Scleroderma is associated with differences in individual routes of drug metabolism: a study with dapsone, debrisoquin, and mephenytoin.

May DG, Black CM, Olsen NJ, Csuka ME, Tanner SB, Bellino L, Porter JA, Wilkinson GR, Branch RA
Clin Pharmacol Ther. 1990 48 (3): 286-95

PMID: 2401127 · DOI:10.1038/clpt.1990.151

MeSH Terms (19)

Acetylation Adult Biotransformation Dapsone Debrisoquin Disease Susceptibility Female Humans Hydantoins Hydroxylation Isoquinolines Logistic Models London Male Mephenytoin Middle Aged Oxidation-Reduction Scleroderma, Systemic Tennessee

Connections (1)

This publication is referenced by other Labnodes entities: